Reporte zur Charge 1EN6199

Symptomtext

Received first dose Pfizer Covid 19 Vaccine and after that developed Covid.; This is a spontaneous report from a contactable consumer (patient) via Pfizer sponsored program . A 73-year-old female patient started to receive first dose of bnt162b2 (BNT162B2, solution for injection, Lot Number: EJ6789), dose 1 via an unspecified route of administration on 11Mar2021 (age at the vaccination 73-year-old) as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications was not reported. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced the caller states her husband tested positive for covid/the caller then tested for covid and also tested positive. On 17Mar2021, received first dose pfizer covid 19 vaccine and after that developed covid on 17Mar2021. The patient underwent lab tests and procedures which included sars-cov-2 antibody test: positive. The caller then tested for Covid and also tested positive. The outcome of events was Unknown. Follow-up attempts are possible. Information on Lot/Batch number was available.